Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Xvivo Perfusion Major Shareholding Notification 2017

Aug 29, 2017

3130_iss_2017-08-29_313a0e32-dfb0-4d02-90c4-a062d918715d.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Xvivo Perfusion Aktiebolag

Holder

Swedbank Robur Fonder AB

Instrument

Instrument Aktier SE0004840718
Before the transaction
Shares 530,000
Voting rights 530,000
Transaction
Reason for major shareholding notification Buy
Date 02/06/2017
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 1,430,000
Directly held voting rights 1,430,000
Indirectly held voting rights 0
Percentage
Directly held shares 5.51 %
Directly held voting rights 5.51 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.51 % 1,430,000
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.51 % 1,430,000
Published
29/08/2017 11:38
Contact
Name Mia Metso Ekberg
Phone 08-58597525
Email [email protected]

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25